Edgewell Personal Care (EPC) has been drawing fresh attention after a period of mixed share performance, with strong recent gains contrasting with weaker longer term returns and modest profitability on more than US$2.2b in annual revenue.
See our latest analysis for Edgewell Personal Care.
The recent 18.56% 1 month share price return and 27.66% 3 month share price return suggest momentum is building in the short term, even as the 1 year total shareholder return of a 24.8% decline and 3 year total shareholder return of a 44.42% decline point to a much tougher longer term journey.
If this move has you reassessing your portfolio, it could be a good time to broaden your search with our 19 top founder-led companies as potential long term compounders to research next.
With Edgewell trading at a roughly 50% discount to one intrinsic value estimate and only a small gap to the average analyst target, investors may question whether there is real upside or whether the market is already pricing in future growth.
With Edgewell Personal Care last closing at $22.80 against a widely followed fair value estimate of about $23.86, the narrative points to a small valuation gap that hinges on how earnings and margins evolve from here.
Sustained productivity and cost efficiency initiatives including automation, global sourcing optimization, and commercial reorganization in North America have delivered significant gross savings (270 to 300 basis points in recent quarters) and are expected to continue, funding incremental brand investment while structurally expanding future operating margins and net income.
Want to see what this story is really built on? Revenue barely moves, yet earnings, margins and the future earnings multiple all shift in very different directions. Curious which assumptions make that math work and how they link to the fair value?
Result: Fair Value of $23.86 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, that story can unravel if reliance on mature shave and sun care categories leads to ongoing volume pressure, or if retailer power keeps squeezing pricing and margins.
Find out about the key risks to this Edgewell Personal Care narrative.
If this mix of short term momentum and longer term weakness feels hard to read, take a closer look now and shape your own view with 3 key rewards and 4 important warning signs.
Do not stop at one stock, this is your chance to line up a watchlist of quality ideas before everyone else starts paying attention.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com